| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 607092000 | Internal application | 58 |
| 20080208297 | Optical Therapy Devices, Systems, Kits and Methods for Providing Therapy to a body Cavity - An optical therapy device is disclosed. The optical therapy device provides therapeutic light therapy to a body cavity. The device includes a housing adapted to be hand held, a UV light source positioned in or on the housing, and an insertion member having a distal end configured to be inserted into the body cavity to illuminate tissue in the body cavity with light from the light source. | 08-28-2008 |
| 20090024191 | MULTI-CLADDING OPTICAL FIBER SCANNER - A multi-cladding optical fiber includes a core that conveys visible light used by a scanner for imaging a site within a patient's body, and an inner cladding that conveys high-power light, such as infrared light, used for providing therapy to site. The distal end of multi-cladding optical fiber is driven to scan the site when imaging or rendering therapy using an actuator. High-power light is coupled into inner cladding at proximal end of optical fiber using several different techniques. Some techniques use an axicon to direct the high-power light into the inner cladding, while visible light is coupled directly into the core. Another technique uses a multimode optical fiber in a coupling relationship with the multi-cladding optical fiber, to transfer high-power light from a core of the multimode fiber into the inner cladding of the multi-cladding optical fiber. | 01-22-2009 |
| 20090118800 | IMPLANTABLE OPTICAL STIMULATORS - Various systems and methods are implemented for in vivo use in a living animal. One such method involves stimulating target cells having light-responsive proteins and includes providing an elongated light-delivery structure in a narrow passageway in the animal, the elongated light-delivery structure having separately-activatable light sources located along the length of the elongated light-delivery structure. The method also includes activating less than all the light sources to deliver light to light-responsive proteins adjacent to the activated light sources along the length of the elongated light-delivery structure, thereby stimulating target cells in vivo. | 05-07-2009 |
| 20090204188 | METHOD AND APPARATUS FOR THE COMBINED APPLICATION OF LIGHT THERAPY, OPTIC DIAGNOSIS, AND FLUID TO TISSUE - In one embodiment there is provided a system for light therapy. The system includes a light guide transmission device having at least one UV bulb for dispersing UV light a light guide cable to a light guide terminating end, an optical capturing device operable to receive an image from a lens positioned at an optical cable terminating end, and a fluid delivery/suction device along a flexible hose. Each of the cables being inserted into a probe cable having a tip adapted for use internally or externally with a patient. Further the system includes a single controller in communication with and for controlling the functionality of the light guide transmission device, the optical capturing device, and the fluid delivery/suction device. | 08-13-2009 |
| 20100145418 | SYSTEM FOR OPTICAL STIMULATION OF TARGET CELLS - Various systems and methods are implemented for controlling stimulus of a cell. One such method is implemented for optical stimulation of a cell expressing an NpHR ion pump. The method includes the step of providing a sequence of stimuli to the cell. Each stimulus increases the probability of depolarization events occurring in the cell. Light is provided to the cell to activate the expressed NpHR ion pump, thereby decreasing the probability of depolarization events occurring in the cell. | 06-10-2010 |
| 20100241198 | Tubular device delivering light and radiation into a patient - A device delivers light within a patient using an inner cannula, fiber optics, LED along an endotracheal tube, ETT or tracheostomy tube or a strip with embedded LED adhered to an ETT. The inner cannula includes a tubular thin walled device that transmits light by fiber optics or delivers electrical power to an LED. The light passes along one or more fibers placed within the walls of the inner cannula for outward delivery of the light. The light affects the inside of the cannula, the area between the cannula and the ETT, the area outside the ETT, and into the tracheobronchial tree. The light delivers an antimicrobial effect into the upper airway of a patient. Alternatively, the light delivery device involves tubes and cannulas attaching to existing medical tubes and devices. Alternatively, a transparent strip of embedded LED secures to an existing medical tube. | 09-23-2010 |
| 20100249890 | PHOTOSTIMULATION APPARATUS - A photostimulation apparatus may include: a membrane for insertion into a living body; and at least one cell disposed on the membrane. Each cell may include a first light source for irradiating light to a photosensitive material in the living body. Further, a photostimulation apparatus may include: a membrane for insertion into a living body; and at least one first light source disposed on the membrane for irradiating light to a photosensitive material in the living body. Since the photostimulation apparatus is placed on the surface of cortex or dura, it may minimize damage of the brain tissue and may activate and/or inhibit a large area simultaneously using light. | 09-30-2010 |
| 20100249891 | IMPLANTABLE APPARATUS FOR THE TREATMENT OF A SURFACE OF A DAMAGED VESSEL OR BODY CAVITY BY ELECTROMAGNETIC ENERGY - The present invention provides an improved apparatus and method for the treatment of body cavities and damaged vessels using electromagnetic energy. A device and apparatus according to the invention may be used to irradiate a tissue surface internal to the body, for example, for treatment of an aneurysm, tissue reconstructing, or removal of an anomaly in a blood vessel. Light energy may be radiated from an implantable and retrievable biocompatible matrix into which is mounted a plurality of electromagnetic energy sources, such as light emitting diodes or the like. | 09-30-2010 |
| 20100274330 | DEVICE FOR TREATMENT OF BLOOD VESSELS USING LIGHT - Light generating devices for illuminating portions of vascular tissue to administer photodynamic therapy, and usable with, or including a distal protection device. A first device includes a hollow tip, a flushing lumen, a guidewire lumen, and at least one of a light source, and a hollow light transmissive shaft that is adapted to accommodate a light source. If desired, the device can include a balloon, so that a portion of a body lumen between the balloon and the distal protection device is isolated when the balloon is inflated. A second device includes inner and outer catheters, the outer catheter including a balloon, and the inner catheter including a light source encompassed by another balloon. Yet another device is a catheter having two balloons and a sleeve extending there between. Within the sleeve, the catheter includes a light source and an expanding member. | 10-28-2010 |
| 20110054574 | Ultraviolet sterilizer for surgery - An ultraviolet sterilizer for use during surgery is mounted in a base cabinet. The UV light source can be a laser, or an LED. An optical frequency multiplier can be used that outputs UV of less than 280 nm, or greater than 320 nm, to avoid burning the patient. A visible LED aiming light directs the UV light toward the surgery. A crosshair image can be projected to position the light. | 03-03-2011 |
| 20110152978 | Systems, devices, and methods including catheters configured to monitor biofilm formation having biofilm spectral information configured as a data structure - Systems, devices, methods, and compositions are described for providing an actively-controllable disinfecting implantable device configured to, for example, treat or prevent an infection in a biological subject. | 06-23-2011 |
| 20110196457 | DEVICE FOR UV PHOTO-THERAPY - Skin disorders such as, for example, atopic dermatitis, dyshidrosis, eczema, lichen planus, psoriasis, and vitiligo, are treated by applying high doses of ultraviolet light to diseased regions of a patient's skin. The dosage exceeds 1 MED as determined for the particular patient and may range from about 1 MED to about 20 MED or higher. The ultraviolet light has a wavelength within the range of about 295 nanometers to about 320 nanometers. High doses of ultraviolet light are preferably restricted to diseased tissue areas. A specialized handpiece provides a beam profile especially suitable for application of controlled doses. A specialized delivery device is useful for UV treatment of tissue within the mouth. | 08-11-2011 |
| 20110282417 | COCHLEA INSERTABLE HEARING PROSTHESIS AND CORRESPONDING SYSTEM AND METHOD - A hearing prosthesis insertable fully or partially into the human cochlea provides for hearing support capabilities to persons with degraded hearing capability or without hearing capability. The hearing prosthesis emits controlled light signals for stimulation of hearing neurons. Using light sources, the transfer of audio signals to a person is realized optically, as opposed to transfer through the use of electrodes. The light signals are controlled in terms of duration, intensity and repetition frequency from the light sources. | 11-17-2011 |
| 20120089207 | LIGHT TRANSMISSION SYSTEM FOR PHOTOREACTIVE THERAPY - A light transmission system to provide photodynamic treatment to a patient includes a single use integrated control module and catheter assembly having a plurality of light emitting diodes (LEDs) to transmit light toward target cells within a patient. The integrated light catheter and control module are used in combination with a light activated drug. Selected operating parameters may be programmed into the control module, or it may be wirelessly programmable in situ prior to use to allow user flexibility to tailor treatment for a particular patient or condition. Among the features that prevent reuse are that the control module lacks access to recharge the power source, and it may include a deactivation module that destroys circuitry or software when triggered. To prevent patient interference when in use, the control module may also be configured to selectively deactivate. | 04-12-2012 |
| 20120136416 | Caged Neuropeptides: modulation and measurement of synapse and signaling activity; and methods for drug evaluation, pharmaceuticals preparation and treatment - A neuropeptide is caged and delivered to a synaptic site, then photolytically activated to enable precise temporal and spatial temporal investigation of localized signaling activity or synaptic responses. Caged molecules, delivery and activation systems clarify the kinetics and activity of neuropeptide-mediated signaling to identify agonists and permit focused drug evaluation for specific diseases and conditions. The caged peptides may also provide light-mediated treatment therapies for localized relief of pain or nerve-related conditions, and serve as a screening or measurement tool for potential agonists and antagonists. A kit includes the caged molecule and may further include a reporter for indicating response to the activated neuropeptide. | 05-31-2012 |
| 20120172952 | OPTICAL STIMULUS PROBE STRUCTURE WITH OPTICAL TRANSMITTABLE PROBE AND MANUFACTURING METHOD THEREOF - Disclosed are an optical stimulation probe structure having a probe body inserted into a subject, a fixing body that fixes the probe body and a light radiator that transmits an optical signal to the probe body, wherein the probe body is made of an optical transmission material capable of transmitting an optical signal, such that the optical signal transmitted from the light radiator is transmitted through the probe body to the subject, and a method for manufacturing the same. | 07-05-2012 |
| 20120191163 | METHOD AND SYSTEM FOR MANIPULATING A CELL - A method of manipulating a living cell is disclosed. The method comprises, directing a pulsed optical field to at least one conductive nanoparticle present in the vicinity of the cell, so as to generate cavitations at or near the conductive nanoparticle at sufficient amount to effect at least one cell modification selected from the group consisting of cell-damage and cell-fusion. | 07-26-2012 |
| 20120209359 | LOW-PROFILE INTRALUMINAL LIGHT DELIVERY SYSTEM AND METHODS OF USING THE SAME - A light delivery system to provide light treatment to a patient includes an elongated catheter having a light emitter that transmits light towards a target site within a patient. The catheter is sized and configured to pass through anatomical body structures to reduce or eliminate trauma associated with the delivery procedure. A visualization system of the catheter can assist a user before, during, and/or after performing light therapy. The visualization system includes sensors that provide real-time imaging or feedback. | 08-16-2012 |
| 20120232618 | DEVICE USED FOR TREATMENT OF RHINITIS BY BIOSTIMULATIVE ILLUMINATION - A device for the treatment of rhinitis by biostimulative illumination. The device comprises a pair of LEDs ( | 09-13-2012 |
| 20120239121 | METHOD OF REDUCING THE OCCURRENCE OF ARRHYTHMIAS VIA PHOTOBIOMODULATION AND APPARATUS FOR SAME - In response to local or systemic inflammation in a patient, photobiomodulation therapy is applied to a cardiac location to reduce the risk and/or occurrence of cardiac arrhythmia. Once inflammation is identified, photobiomodulation therapy can be applied in any suitable fashion (e.g., via a catheter- or transesophageal probe-mounted photoemitter, via an externally-applied photoemitter, or via photoemitter incorporated into an implantable medical device). Photobiomodulation therapy can also be employed to good advantage in conjunction with non-photobiomodulation therapy (e.g., traditional cardiac rhythm management therapies). | 09-20-2012 |
| 20120259393 | Implantable Device for Optically Stimulating the Brain of a Person or an Animal - The invention relates to an implantable device for optically stimulating the brain of a person or an animal, the device comprising:
| 10-11-2012 |
| 20130013031 | CAPSULE PHOTOTHERAPY - The present invention provides a swallowable capsule suitable for providing phototherapy to a region of a patient's gastrointestinal (GI) tract, the capsule comprising one or more light sources emitting in the visible and/or NIR ranges and optical elements for shaping the light beam produced by said light sources, such that said light source(s) and said optical elements are capable of delivering an effective therapeutic dose to a target site within the GI tract. The present invention further provides a method for intraluminal phototherapy of the gastrointestinal tract using a swallowable capsule as described hereinabove. | 01-10-2013 |
| 20130030507 | PROBE DEVICE, SYSTEM AND METHOD FOR PHOTOBIOMODULATION OF TISSUE LINING A BODY CAVITY - A device is presented for use in treatment of tissues inside a body cavity. The device comprises a probe member having at least a portion thereof carrying a plurality of light sources, at least said portion of the probe member having dimensions and shape suitable for insertion into a certain body cavity and for arranging within the surface thereof a three-dimensional array of said light sources, the light sources being configured and operable to irradiate optical energy outwardly from said probe member. | 01-31-2013 |
| 20130103124 | METHODS FOR DELIVERY OF OPTICAL SIGNALS TO TISSUE FOR THE TREATMENT OF A DISEASE OR CONDITION - Embodiments described herein provide methods for treating various conditions and diseases using an optical signal. In one or more embodiments an apparatus is providing having an optical window, which is used to deliver an optical signal to provide stimulation to one or more tissue sites in the body such as the brain, optic nerve, eye, ganglia, spine, or other like site. The optical signals can be used to treat a variety of neurological diseases and conditions including epilepsy, migraine headaches and chronic pain. In particular applications the optical signals can be used to treat, inhibit or prevent epileptic or other neurological seizures by providing an optical input to a foci or surrounding tissue in the brain causing the seizure. The optical signal may also be combined with an electrical signal to produce an aggregate effect in tissue for treating the disease or condition such as a neurological disease or condition. | 04-25-2013 |
| 20130178921 | SYSTEM AND APPARATUS PROVIDING A CONTROLLED LIGHT SOURCE FOR MEDICINAL APPLICATIONS - An application for a light source for killing blood pathogens. The light source includes multiple ultraviolet light emitting diodes and a visible-spectrum light emitting diode. A light mixer combines light from the ultraviolet light emitting diodes and the visible-spectrum light emitting diode and focuses a mixed light into a fiber optic for delivery to an intravenous needle. A controller adjusts an amount of current delivered to the ultraviolet light emitting diodes and visible-spectrum light emitting diode. A touch screen is interfaced to the controller for inputting commands and a display is interfaced to the controller for outputting information. | 07-11-2013 |
| 20130282082 | LIGHT IRRADIATION DEVICE, AND LIGHT IRRADIATION TREATMENT AND PREVENTION DEVICE PROVIDED THEREWITH - A light irradiation device of the present invention includes: a light source that emits radiant light to an irradiation object; a reflecting member that reflects the radiant light emitted from the light source toward the irradiation object; and an irradiation member that includes at least two irradiation surfaces for transmitting the radiant light reflected from the reflecting member and irradiating the irradiation object with the radiant light. The light source emits the radiant light from one end side of the irradiation surfaces of the irradiation member, and the reflecting member includes: a first reflecting area that reflects the radiant light emitted from the light source toward a first irradiation surface of the irradiation member; a second reflecting area that reflects the radiant light emitted from the light source and indirectly reaches the second reflecting area, toward a second irradiation surface of the irradiation member; and a third reflecting area that guides the radiant light to the second reflecting area. Therefore, the light irradiation device and a light irradiation treatment and prevention device, which can irradiate a plurality of irradiation surfaces with the radiant light using one light source, can be configured. | 10-24-2013 |
| 20130289675 | Materials and Approaches for Optical Stimulation of the Peripheral Nervous System - A variety of methods, devices, systems and arrangements are implemented for stimulation of the peripheral nervous system. Consistent with one embodiment of the present invention, method is implemented in which light-responsive channels or pumps are engineered in a set of motor units that includes motor units of differing physical volumes. Optical stimuli are also provided to the light-responsive channels or pumps at an optical intensity that is a function of the size of motor units to be recruited. In certain implementations, the intensity of the optical stimuli is increased so as to recruit increasingly larger motor units. | 10-31-2013 |
| 20130289676 | Methods, Systems and Devices for Optical Stimulation of Target Cells Using an Optical Transmission Element - Stimulation of target cells using light, e.g., in vivo, is implemented using a variety of methods and devices. In one such device, target cells are stimulated using an implantable device. The device includes a light source for producing light from electrical power. An optical transmission element is made from a material that is substantially transparent to the light from the light source. This transmission element substantially encases the light source at a proximal end. The transmission element delivers light from the light source to a distal end. The shape and size of the transmission element facilitates implanting of the element within a patient. A fixation portion physically couples to the optical transmission element and secures the device to the patient. A heat dissipation portion removes heat from the near optical transmission element and the light source and dissipates the removed heat through the fixation portion. | 10-31-2013 |
| 20130317575 | Implantable Optical Stimulators - Various systems and methods are implemented for in vivo use in a living animal. One such method involves stimulating target cells having light-responsive proteins and includes providing an elongated light-delivery structure in a narrow passageway in the animal, the elongated light-delivery structure having separately-activatable light sources located along the length of the elongated light-delivery structure. The method also includes activating less than all the light sources to deliver light to light-responsive proteins adjacent to the activated light sources along the length of the elongated light-delivery structure, thereby stimulating target cells in vivo. | 11-28-2013 |
| 20140005758 | CAPSULE PHOTOTHERAPY | 01-02-2014 |
| 20140081360 | CAPSULE PHOTOTHERAPY - A method for providing phototherapy to a GI tract including using a capsule imager to scan at least a portion of a GI tract, estimating a location of a diseased portion of the GI tract, and based, at least in part, on the estimated location, using a phototherapy capsule to provide phototherapeutic light to the diseased portion. | 03-20-2014 |
| 20140128943 | IMPLANTABLE CLIPT ILLUMINATION SYSTEM - A light-based therapy device is provided that includes a controller mechanism that produces power and control signals to enable operation of one or more medical devices. An implantable light delivery device (IM-LDD) is coupled to the controller mechanism that receives the power and the control signals to enable a light source to emit sufficient illumination. The light source is implanted within body cavities enabling energy at one or more wavelengths to reach and provide therapy treatment to a selected region. | 05-08-2014 |
| 20140188198 | HYPODERMIC NEEDLE WITH FIBEROPTIC EXTENSION - A device for treating disease has a hypodermic needle having a hollow shaft and an insertion tip, at least one fiberoptic filament extending through the needle to the insertion tip, and a UV light source connected to the fiberoptic filament. The UV light source is adapted to transmit UV light at a wavelength of 280-100 nm. The hypodermic needle is inserted into a patient until the insertion tip is located in an area to be treated, and the UV light is supplied to the at least one fiberoptic filament, so that the light travels along the filament to the area to be treated. | 07-03-2014 |
| 20140207214 | APPARATUS AND METHODS FOR CONTROLLING AND APPLYING FLASH LAMP RADIATION - Apparatus and methods are disclosed for treating allergic rhinitis (seasonal and perennial hay fever), by application of flash lamp radiation. The nasal cavity can be illuminated in a safe and effective manner, with non-coherent light from a flash-lamp or other suitable source. This illumination can be accomplished in any suitable manner, including by use of a handheld device. Such handheld embodiments may contain a power source (battery or AC), control circuitry, light source (flash-lamp or diode laser), lens (focusing or non-focusing), light filter, and/or fiber-optic for delivering light to the nasal cavity. Embodiments include using any suitable light energy, such as visible light in the red wavelengths with a power output of 1 to 10 Joules per cm | 07-24-2014 |
| 20140236270 | METHOD AND OCULAR IMPLANT FOR TRANSMISSION OF NERVE-STIMULATION LIGHT - An improved prosthesis and method for stimulating vision nerves to obtain a vision sensation that is useful for the patient that has lost vision due to age-related macular degeneration (AMD) and retinitis pigmentosa (RP) and other diseases. The present invention utilizes infrared light to cause action potentials in the retinal nerves similar to those which result from rods and cones stimulated by visible light in healthy retinas. In some embodiments, the invention provides a pathway or “image pipe” for transmitting a stimulation pattern of infrared light from an external stimulator array through the eye and focusing the stimulation pattern of infrared light on the retina, especially the fovea. Some embodiments provide improved resolution down to a group of nerves, or even the individual nerve level, with sufficient energy density so as to cause a desired action potential. | 08-21-2014 |
| 20140243937 | Red Light Implant for Treating the Spine - Red light-emitting implants for treating a spine. | 08-28-2014 |
| 20140324138 | Wirelessly-powered illumination of biological tissue - In exemplary implementations of this invention, an implant device is wholly or partially implanted in a mammal. The implant device includes an antenna, circuitry, a supercapacitor, one or more light sources, and an array of optical fibers or light guides. The antenna and circuitry receive energy by wireless transmission from an external transmit coil. The supercapacitor stores at least a portion of the energy and provides power to one or more light sources. The array of optical fibers or light guides deliver light from the light sources to living tissue of a mammal. The tissue includes light-sensitive, heterologously expressed proteins. The light affects the light-sensitive proteins, triggering a change in all or part of the tissue, such as a change in voltage, pH or a change in function. | 10-30-2014 |
| 20140358199 | Self-administrable method, system and apparatus for non-invasive neurostimulation therapy of the brain - The present invention is a portable non-invasive apparatus, system, and method for performing light therapy or photobiomodulation upon the brain tissues through the nostrils of a living mammalian subject for the medical purpose of stimulating the brain in-vivo. In marked difference to conventionally known therapeutic procedures, the present invention utilizes the intranasal pathway as the point of anatomic access; and follows established principles for the conceptual approach that irradiation of the brain tissue with low level light energy of certain fixed parameters would achieve major therapeutic effects in-vivo. In this manner, the present invention utilizes light energy of specified wavelengths, coherency, and pulsed mode to achieve therapeutic outcomes. | 12-04-2014 |
| 20150012072 | VASCULAR ACCESS DEVICE WITH INTEGRATED LIGHT GUIDE - A system for irradiation of a vascular space and its contents is presented. An adapter device having a vascular access end and an optical interface end can include a waveguide affixed within a waveguide lumen and extending outwardly through the vascular access end. The optical interface end includes a tapered terminus configured to engage with a cavity of an optical connector adapter, creating an optical interface between the waveguide of the adapter device and a waveguide of a light or radiation source. The adapter device enables the simultaneous administration of radiation and exogenous fluids to a patient while maintaining the optical interface isolated from any fluids. | 01-08-2015 |
| 20150018901 | Neural prosthetic device and method of making same - A neural prosthetic device can selectively deliver light to different cortical layers, at different depths, in the brain. The device includes LEDs and corresponding waveguides that can extend into the brain. At least two of the waveguides have different lengths. The neural prosthetic device or other devices can be manufactured by changing the hydrophilicity or lyophilicity of a portion of a substrate layer, then depositing uncured polymer on the treated portion of the substrate layer. The uncured polymer flows under the influence of surface tension to form a volume. The volume is shaped as a dome that extends laterally to a boundary between the treated and untreated portions. The polymer is cured in discrete regions through the substrate layer. The discrete regions extend longitudinally from the substrate layer to a curved surface of the dome. The uncured portion of the polymer is removed. The cured regions form the waveguides. | 01-15-2015 |
| 20150142086 | ACCELERATING METHOD, OPTOMEDICAL DEVICE, AND OPTOMEDICAL SYSTEM - A method for accelerating the release of neurotransmitters includes a step of radiating light from within a cerebral blood vessel to accelerate the release of the neurotransmitters. An optomedical device includes a main body configured to be introduced into a cerebral blood vessel; a light emitting unit arranged on the main body, the light emitting unit configured to radiate light to accelerate the release of neurotransmitters; and a control unit configured to control a light emitting action of the light emitting unit. | 05-21-2015 |
| 20150306415 | IMPLANTABLE DEVICE WITH OPTICAL LEAD - An implantable active medical device system includes an active medical device and a lead extending between a proximal portion electrically coupled to the active medical device and a distal end portion configured to emit light. The distal end portion includes a solid state light source disposed within a light transmissive ring element. The light transmissive ring element forms an exterior segment of the distal end portion. The light transmissive ring element defines at least a portion of a hermetic cavity. | 10-29-2015 |
| 20160038755 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-11-2016 |
| 20160038756 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-11-2016 |
| 20160038757 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-11-2016 |
| 20160038758 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-11-2016 |
| 20160051830 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-25-2016 |
| 20160051836 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-25-2016 |
| 20160051837 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-25-2016 |
| 20160051838 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 02-25-2016 |
| 20160059034 | LED BASED VAGINAL LIGHT THERAPY DEVICE - The embodiments herein provide an LED based vaginal light therapy device for a plurality of bacterial and fungal infections. The device comprises an LED body, a cervix support, a single or a plurality of LEDs, a switch, a tether, microchip and a battery. One end of the device comprises a cervix support to place the device smoothly against the cervix. A plurality of LEDs is provided over the LED body. The LED body comprises one or more LEDs and each LED emits a light having a wavelength in a therapeutic zone of light. The light emitted are in a range of blue light and/or red light. The microchip is housed within the LED body. The microchip connects a battery to the single or plurality of LED's and is further connected to the switch. | 03-03-2016 |
| 20160082279 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 03-24-2016 |
| 20160096034 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 04-07-2016 |
| 20160096035 | SYSTEM AND METHOD FOR OPTOGENETIC THERAPY - Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells. | 04-07-2016 |
| 20160114185 | Internal UV Treatment Administered Via Endoscopy - A device and method is proposed to enable the treatment of interior of bodily hollow organs and other interior cavities of a body for a number of harmful virus, fungal, and bacterial entities and autoimmune conditions by internal short wavelength ultraviolet light by use of specially equipped endoscope-like devices. | 04-28-2016 |
| 20160129278 | PROBE DEVICE, SYSTEM AND METHOD FOR PHOTOBIOMODULATION OF TISSUE LINING A BODY CAVITY - A device is presented for use in treatment of tissues inside a body cavity. The device comprises a probe member having at least a portion thereof carrying a plurality of light sources, at least said portion of the probe member having dimensions and shape suitable for insertion into a certain body cavity and for arranging within the surface thereof a three-dimensional array of said light sources, the light sources being configured and operable to irradiate optical energy outwardly from said probe member. | 05-12-2016 |
| 20160151639 | DEVICES AND METHODS FOR DELIVERY OF THERAPEUTIC ENERGY | 06-02-2016 |
| 20160166847 | LIGHT THERAPY DEVICE FOR RHINITIS OR TYMPANITIS TREATMENT | 06-16-2016 |
